{"Q": 1, "answer": "no", "rationale": "The segment contains 'highly pathogenic avian influenza', which is a technical term and does not trigger Q1.", "method": "llm_batch", "batch_id": "batch_1_156", "batch_size": 200, "batch_pos": 63, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The segment provides factual information about vaccine development without high-potency verbs or metaphors.", "method": "llm_batch", "batch_id": "batch_2_15720", "batch_size": 200, "batch_pos": 56, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
{"hop_idx": 3, "answer": "uncertain", "rationale": "Missing response from batch", "method": "fallback", "batch_id": "batch_3_18976", "batch_size": 200, "batch_pos": 30, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "The segment describes funding use for vaccine development, not the impact of the virus using a moderate verb and scale.", "method": "llm_batch_retry", "retry": 1, "batch_id": "batch_3_18976_r1", "batch_size": 200, "batch_pos": 30, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_13780", "batch_size": 200, "batch_pos": 17, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "The segment describes the use of funds for vaccine development and testing, lacking explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_16920", "batch_size": 200, "batch_pos": 16, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "The segment does not contain a minimiser used in conjunction with a scale contrast.", "method": "llm_batch", "batch_id": "batch_6_17300", "batch_size": 200, "batch_pos": 1, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_17708", "batch_size": 200, "batch_pos": 197, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
{"Q": 8, "answer": "yes", "rationale": "Describes a future development/testing capability ('will be used to complete late-stage development and testing') without active reassurance.", "method": "llm_batch", "batch_id": "batch_8_19332", "batch_size": 200, "batch_pos": 157, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
